medmix AG operates through two primary segments: Healthcare and Consumer & Industrial. The Healthcare segment, which accounts for the majority of the company's gross profit, provides drug delivery systems such as injection pens, surgical tools for bone tissue injection, and mixing tips and cartridges for dental applications. The Consumer & Industrial segment supplies micro-brushes and cosmetic applicators for the beauty industry, alongside dispensers and mixers for two-component adhesives used in construction, automotive, and electronics. Operating 14 production sites worldwide, the company employs over 2,500 people and holds more than 900 active patents. medmix was established as an independent entity following its spin-off from Sulzer AG and subsequent listing on the SIX Swiss Exchange in 2021. The company's competitive position stems from its ability to apply high-precision fluid management and injection technologies across both medical fields and diverse industrial applications.
